Skip to content
InSilens, Biotech Intelligence
Login
  • Home
  • Signals
  • Contact us
  • Subscribe
Explore the platform
InSilens, Biotech Intelligence
INSILENS, A Noetera Company

Biotech Intelligence Platform

Turn Global Biotech Signals, Into Strategic Intelligence

Explore with us

Biotech Signals. Structured for Decisions.

INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.

Deals and Financing
Pfizer – SF R&D Site Closure
April 9, 2026
Gilead – $5B Tubulis Acquisition
April 9, 2026
Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
April 1, 2026
Fortress Biotech, $205M Priority Review Voucher Sale
April 16, 2021
Therapeutic Indication
Gilead – $5B Tubulis Acquisition
April 9, 2026
Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
April 1, 2026
Alltrna / tRNA Therapy – First Clinical Trial Approaching for Nonsense Mutation Diseases
April 1, 2026
Tempest Therapeutics – CAR-T Expansion and TPST-2003 Interim Data in Multiple Myeloma
April 1, 2026
Technology Modalities
Life Biosciences – $80M Gene Therapy Financing
April 9, 2026
Orca Bio – FDA Extends Orca-T Review Timeline
April 9, 2026
Alltrna / tRNA Therapy – First Clinical Trial Approaching for Nonsense Mutation Diseases
April 1, 2026
Fortress Biotech, $205M Priority Review Voucher Sale
April 16, 2021
View all

Weekly Market Insight

Fortress Biotech, $205M Priority Review Voucher Sale
Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Gilead – $5B Tubulis Acquisition
Pfizer – SF R&D Site Closure
    • Home page
    • Signals
    • Contact us
    • Subscribe

 

  • Deals and Financing
  • Therapeutic Indication
  • Technology Modalities

Contact Us

Need help or have a question?
Contact us at: info@insilens.com

  • Privacy Policy
  • Terms & Conditions

 

Our company

InSilens is a biotech intelligence platform transforming global signals into actionable insights for investors, researchers, and industry leaders. A product of Noetera.

© 2026 InSilens. All rights reserved. A Noetera Company